Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections
Authors:
- S. EspositoSES. Esposito
- I. EspositoIEI. Esposito
- S. LeoneSLS. Leone
- 24 July 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (11) , 2570-2575
Abstract
Despite the large number of suggestions available in the literature, the optimal duration of antibiotic treatment remains an individual decision mainly based on clinical criteria. Shorter but equally effective regimens would reduce the side effect rates, including both antibiotic resistance and drug expenses. Although several prospective, randomized trials and meta-analyses with the aim of comparing a standard duration with a shorter one for most bacterial infections have been published, to date most current recommendations carry little weight, as they are based on expert opinions or practical experience. This review will briefly touch upon the clinical evidence of short-course versus long-course antibiotic therapy for the most common community- and hospital-acquired bacterial infections.Keywords
This publication has 43 references indexed in Scilit:
- The Perpetual Challenge of Infectious DiseasesNew England Journal of Medicine, 2012
- Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic ReviewClinical Infectious Diseases, 2011
- Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial optionsInternational Journal of Antimicrobial Agents, 2011
- Strategies for Reduction in Duration of Antibiotic Use in Hospitalized PatientsClinical Infectious Diseases, 2011
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract InfectionsJAMA, 2009
- The Maxwell Finland Lecture: For the Duration-- Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficileClinical Infectious Diseases, 2008
- Short- versus Long-Course Antibacterial Therapy for Community-Acquired PneumoniaDrugs, 2008
- High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment ParadigmClinical Infectious Diseases, 2003
- Practice Guidelines for the Diagnosis and Management of Group A Streptococcal PharyngitisClinical Infectious Diseases, 2002
- Resolution of Infectious Parameters after Antimicrobial Therapy in Patients with Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001